Compared to the matched controls, BRCA1/2 carriers had statistically significant increased breast cancer rates (adjusted HR 7.40, CI 5.81–9.42), but after BRRM, the rate did not differ (adjusted HR 0.47, CI 0.12–1.90) (Table 3). The gene discussed is BRCA1; the disease is breast carcinoma.